LANXESS Aktiengesellschaft (FRA:LX9B)

Germany flag Germany · Delayed Price · Currency is EUR
3.080
-0.040 (-1.28%)
At close: Jun 26, 2026
Market Cap1.40B -36.4%
Revenue (ttm)5.45B -14.3%
Net Income-661.00M
EPS-7.66
Shares Out n/a
PE Ration/a
Forward PE24.09
Dividend0.01 (0.34%)
Ex-Dividend DateMay 22, 2026
Volumen/a
Open3.080
Previous Close3.120
Day's Range3.060 - 3.080
52-Week Range2.100 - 5.250
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 7, 2026

About FRA:LX9B

LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The company provides material protection products; disinfectant, hygiene, and preservative solutions; flavors and fragrances; liquid purification technologies for the treatment of water and other liquids; and precursors and intermediates for the ag... [Read more]

Industry Plastics Materials And Synthetic Resins, Synthetic Rubber, Cellulosic And Other Manmade Fibers, Except Glass
Founded 1863
Employees 11,630
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol LX9B

Financial Performance

In 2025, FRA:LX9B's revenue was 5.67 billion, a decrease of -10.89% compared to the previous year's 6.37 billion. Losses were -577.00 million, 226.0% more than in 2024.

Financial Statements

News

EQS-DD: LANXESS Aktiengesellschaft: Dr. Hubert Fink, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 22.06.2026 / 10:01 CET/CEST The issuer is solely responsi...

5 days ago - Wallstreet:Online

EQS-DD: LANXESS Aktiengesellschaft: Frederique van Baarle, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 19.06.2026 / 09:10 CET/CEST The issuer is solely responsi...

8 days ago - Wallstreet:Online

EQS-DD: LANXESS Aktiengesellschaft: Oliver Stratmann, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 18.06.2026 / 09:54 CET/CEST The issuer is solely responsi...

9 days ago - Wallstreet:Online

EQS-DD: LANXESS Aktiengesellschaft: Matthias Zachert, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 18.06.2026 / 09:25 CET/CEST The issuer is solely responsi...

9 days ago - Wallstreet:Online

Lanxess price target lowered to EUR 17.50 from EUR 19 at Citi

Citi lowered the firm’s price target on Lanxess (LNXSF) to EUR 17.50 from EUR 19 and keeps a Neutral rating on the shares.

21 days ago - TheFly

Lanxess downgraded to Sell from Neutral at Goldman Sachs

Goldman Sachs downgraded Lanxess (LNXSF) to Sell from Neutral with a price target of EUR 13, down from EUR 21. The Middle East conflict has raised questions around the company’s…

5 weeks ago - TheFly

Lanxess downgraded to Neutral from Overweight at JPMorgan

JPMorgan downgraded Lanxess (LNXSF) to Neutral from Overweight with an EUR 18 price target as part of a broader sector note on European Chemicals. The firm sees limited absolute upside…

5 weeks ago - TheFly

LANXESS Aktiengesellschaft Transcript: AGM 2026

Amid a challenging market, sales and EBITDA declined, but debt was halved and liquidity remains strong. Strategic restructuring, cost-saving programs, and sustainability initiatives are underway, with a stable dividend proposed and cautious optimism for future recovery.

5 weeks ago - Transcripts

Lanxess downgraded to Underperform from Hold at Jefferies

Jefferies downgraded Lanxess (LNXSF) to Underperform from Hold with a price target of EUR 16, down from EUR 17. The firm cites the 53% share price rally from the March…

5 weeks ago - TheFly

LANXESS Aktiengesellschaft Earnings Call Transcript: Q1 2026

Q1 2026 saw a slow start but improved momentum in March, with Q2 expected to show strong sequential gains driven by both volume and pricing. Full-year guidance is maintained, supported by cost savings and positive segment trends, though geopolitical risks remain.

7 weeks ago - Transcripts

LANXESS Aktiengesellschaft Slides: Q1 2026

LANXESS Aktiengesellschaft has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.

7 weeks ago - Filings

LANXESS Aktiengesellschaft Quarterly report: Q1 2026

LANXESS Aktiengesellschaft has published its Q1 2026 quarterly earnings report on May 7, 2026.

7 weeks ago - Filings

LANXESS Aktiengesellschaft Earnings release: Q1 2026

LANXESS Aktiengesellschaft released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.

7 weeks ago - Filings

LANXESS Aktiengesellschaft Earnings Call Transcript: Q1 2026

Q1 2026 saw sales and EBITDA decline sharply year-over-year, but March brought improving demand and volumes. Full-year EBITDA guidance is maintained, with price increases underway and cost discipline in focus amid ongoing geopolitical and supply chain risks.

7 weeks ago - Transcripts

LANXESS Aktiengesellschaft Quarterly report: Q1 2026

LANXESS Aktiengesellschaft has published its Q1 2026 quarterly earnings report on May 7, 2026.

7 weeks ago - Filings

LANXESS Aktiengesellschaft Earnings release: Q1 2026

LANXESS Aktiengesellschaft released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.

7 weeks ago - Filings

Lanxess downgraded to Equal Weight from Overweight at Morgan Stanley

Morgan Stanley downgraded Lanxess (LNXSF) to Equal Weight from Overweight with a price target of EUR 20, down from EUR 26. The firm adjusted ratings in the European industrial chemicals…

3 months ago - TheFly

Lanxess upgraded to Overweight from Underweight at JPMorgan

JPMorgan analyst Chetan Udeshi double upgraded Lanxess (LNXSF) to Overweight from Underweight with a price target of EUR 18, up from EUR 15. The company’s “disruption tailwinds” and cost savings…

3 months ago - TheFly

LANXESS Aktiengesellschaft Earnings Call Transcript: Q4 2025

Full-year EBITDA met guidance at €510 million, with net debt reduced and strong liquidity maintained. 2026 outlook remains cautious amid geopolitical and market volatility, but cost savings and portfolio focus position the company for recovery if volumes improve.

3 months ago - Transcripts

LANXESS Aktiengesellschaft Annual report: Q4 2025

LANXESS Aktiengesellschaft has published its Q4 2025 annual report on March 19, 2026.

3 months ago - Filings

LANXESS Aktiengesellschaft Earnings release: Q4 2025

LANXESS Aktiengesellschaft released its Q4 2025 earnings on March 19, 2026, summarizing the period's financial results.

3 months ago - Filings

LANXESS Aktiengesellschaft Slides: Q4 2025

LANXESS Aktiengesellschaft has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 19, 2026.

3 months ago - Filings

LANXESS Aktiengesellschaft Earnings Call Transcript: Q4 2025

Sales and EBITDA declined sharply year-over-year amid weak demand, high energy costs, and Asian competition. Major divestments and cost-saving measures, including 550 job cuts, were implemented to strengthen the balance sheet and support future growth.

3 months ago - Transcripts

LANXESS Aktiengesellschaft Earnings release: Q4 2025

LANXESS Aktiengesellschaft released its Q4 2025 earnings on March 19, 2026, summarizing the period's financial results.

3 months ago - Filings

Lanxess shares plunge after Advent calls off Envalior stake deal

Lanxess shares ​were set for their worst day ever after the German ‌specialty chemicals maker said the sale of its stake in plastics joint venture Envalior had been called off, one of the first deals ...

4 months ago - Reuters